Measurement of an amorphous form in a pharmaceutical drug product using FT-Raman spectroscopy

American Pharmaceutical Review

Volumn 13, Issue 5, 2010, Pages 34-41

  Zhou, Yong ^a   LoBello, Rebecca ^a   Cai, Chunsheng ^a   Crane, Nicole ^a   Poshni, Faiza ^a   Porter III, William W ^a   Cain, Yanxi Tan ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATOMIC FORCE MICROSCOPY; CRYSTALLIZATION; DRUG FORMULATION; DRUG INDUSTRY; DRUG MANUFACTURE; FOURIER TRANSFORM MASS SPECTROMETRY; MOISTURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAMAN SPECTROMETRY; SOLID STATE; THERMAL ANALYSIS; X RAY DIFFRACTION;

EID: 77956417655     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. G. Winter, "Polymorphs and Solvates of Molecular Solids in the Pharmaceutical Industry". Editor(s): E. Boldyreva and V. Boldyrev. Molecular Solid State, 3 (1999) 241-270.
2. Y. Zhou, N. Crane, C. Cai and Y. T. Cain, "Model for Raman Spectroscopic Monitoring of Process-induced Pseudomorph Interconversion", American Pharmaceutical Review, 12 (4), (2009) 56-63.
3. C. Saal, "Quantification of Polymorphic Forms by Raman Spectroscopy", American Pharmaceutical Review, 9 (4) (2006) 76-81.
4. B. Hancock and G. Zografi, "Characteristics and Significance of the Amorphous State in Pharmaceutical Systems", Journal of Pharmaceutical Sciences, 86(1) (1997) 1-12.
5. J. K. Guillory, "Generation of Polymorphs, Hydrates, Solvates and Amorphous Solids", Drug and the Pharmaceutical Sciences, (Polymorphism in Phamarceutical Solids), 95 (1999) 183-226.
6. J. Faber, "Application of Powder Diffraction studies of Materials That Contain Crystalline and Amorphous Constituents", American Pharmaceutical Review, 4 (2) (2001) 46-52.
7. A. Newman, D. Engers, S. Bates, I. Ivanisevic, R. C. Kelly and G. Zografi, "Characterization of Amorphous Active Pharmaceutical Ingredient (API): Polymer Mixtures Using X-ray Powder Diffraction", Journal of Pharmaceutical Sciences, 97(11) (2008) 4840-4856.
8. M. Phipps and L.A. Mackin, "Application of Isothermal Microcalorimetry in Solid State Drug Development", Pharmaceutical Science & Technology Today, 3(1) (2000) 9-17.
9. N. Fagegaltier, A. Lamure, C. Lacabanne, C. Caron, H. Mifsud and M. Bauer, "Thermal Analysis of Amorphous Phase in a Pharmaceutical Drug", Journal of Thermal Analysis, 48(3) (1997) 459-464.
10. H. Robin, "Applications of Solid-state NMR to Pharmaceutical Polymorphism and related matters", The Journal of Pharmacy and Pharmacology, 59 (2) (2007) 225-239.
11. A. Heinz, C. Strachan, K. Gordon and T. Rades, "Analysis of Solid-state Transformations of Pharmaceutical Compounds Using Vibrational Spectroscopy", Journal of Pharmacy and Pharmacology, 61(8) (2009) 971-988.
12. B. Connolly, T. Patapoff, Y. J. Wang, J. Moore and T.J. Kamerzell, "Vibrational Spectroscopy and Chemometrics to Characterize and Quantitate Trehalose Crystallization", Analytical Biochemistry, 399 (1) (2010) 48-57.
13. L. S. Taylor, "Raman Spectroscopy as a tool to Probe Solid State Form in Tablets", American Pharmaceutical Review, 4(4) (2004) 60-67.
14. A. M. Tudor, S. J. Church, P. J. Hendra, M. C. Davies and C. D. Melia, "The Qualitative and Quantitative Analysis of Chlorpropamide Polymorphic Mixtures by Near-Infrared Fourier Transform Raman Spectroscopy", Pharmaceutical Research, 10 (12) (1993) 1772-1776.
15. Y. Goggo, K. Degardin and P. Margot, "Identification of Pharmaceutical Tablets by Raman Spectroscopy and Chemometrics", Talanta, 81 (2010) 988-995.
16. L. F. Petrovic, L. K. Gvozdenovic and S. E. Antonic, "The Effects of the Fine Grinding on the Physicochemical Properties and Thermal Behavior of Bentonite Clay", J. Serb. Chem. Soc. 67(11) (2002) 753-760.
17. M. J. Pelletier, "Quantitative Analysis Using Raman Spectrometry", Applied Spectroscopy, 57(1) (2003) 20A-39A.